Rhonda Farnum - 08 Jun 2023 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, COMM & MEDICAL AFFAIRS
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
08 Jun 2023
Net transactions value
-$19,923
Form type
4
Filing time
12 Jun 2023, 18:08:11 UTC
Previous filing
23 May 2023
Next filing
22 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Sale $19,923 -1,790 -0.5% $11.13 352,833 08 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023.